All News

RheumNow Podcast square

RheumNow Podcast - Best of EULAR 2021

Jack Cush, MD

Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting.

Read Article
lupus.jpg

How Do You Measure Success When It Comes to SLE?

Kathryn H. Dao, M.D.

EULAR 2021 opened with a grand debate to answer this essential question:  should clinicians treat to remission or to Lupus Low Disease Activity State (LLDAS)?  

Read Article
light-bulbs-1125016_640.jpg

Lessons learned in SLE

Janet Pope, MD, MPH, FRCPC

An analysis of SLE samples from SLE 1760 patients with active disease from RCTs illustrated several known and some new targets for SLE treatment (POS0351).

Read Article
DPGN, lupus, nephritis, GN, glomerulonephritis, biopsy, kidney

Combination vs. Sequential Therapy for the Treatment of Lupus Nephritis

Kathryn H. Dao, M.D.

Combination disease modifying antirheumatic drug (DMARD) therapy may not be only for rheumatoid arthritis; combining disease modifying agents may be the path to better renal response. 

Read Article
malar lupus

Promising options to treat mucocutaneous disease in SLE

Md Yuzaiful Md Yusof, MRCP(UK), PhD

Cutaneous lupus erythematosus (CLE) consists of a wide range of dermatologic manifestations seen in people with or without systemic lupus erythematosus (SLE). CLE can be categorised into LE-specific lesions, i.e.

Read Article
audience learn

EULAR 2021 - Day 3 Report

Jack Cush, MD

Here are a few notable presentations from this past Friday, Day 3 of the EULAR 2021 virtual meeting.

Read Article
COVID vaccine vials

Israel provides COVID vaccine answers for rheumatic disease patients

David Liew, FRACP

The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheumatologists’ offices everywhere this year, and at the EULAR 2021 Virtual Congress, data presented from Israel, one of the first countries to vaccinate on a br

Read Article
What is the impact of mental health and nephritis on SLE? Watch the video from Dr. Janet Pope ( @Janetbirdope ) as she reviews abstract POS0351, POS0681 and POS0304 presented at the virtual #EULAR2021 meeting. https://t.co/neJIdKkhJi https://t.co/YGXUHBsG3d

Links:

Dr. John Cush RheumNow ( View Tweet)
Promising options to treat mucocutaneous disease in SLE #EULAR2021 https://t.co/JoChBNRfqu https://t.co/6jjhuEOQgO

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: Combination DMARD for Lupus Nephritis: Dr. Kathryn Dao ( @KDAO2011 ) #EULAR2021 https://t.co/RGVZ6jukYy https://t.co/PTjSOfM7YQ

Links:

Dr. John Cush RheumNow ( View Tweet)
Current approach to lupus and pregnancy by Dr. Robert Chao ( @doctorRBC) #EULAR2021 https://t.co/eFd6j9YZo5 https://t.co/tW9tJIRpjm

Links:

Dr. John Cush RheumNow ( View Tweet)
#EULAR2021 - Day 3 Report https://t.co/X7zxsKW8eL https://t.co/OKu5Mgodlo

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: IFN Scores Predict Resistance to Skin Disease During RTX Therapy in Lupus Dr. Yuz Yusof speaks with Dr. Lucy Carter about abstract OP0134, presented at the virtual #EULAR2021 meeting. https://t.co/pqr8uRBiRG https://t.co/lhvuYIfI34

Links:

Dr. John Cush RheumNow ( View Tweet)
Video: Prevalence of Long Term HCQ in Retinal Toxicity: Dr. Kathryn Dao (@KDAO2011 ) Dr. Kathryn Dao reviews abstract OP0133, "The Prevalence and Risk Factors of Retinal Toxicity Associated with Long-Term Hydroxychloroquine Use", presented at #EULAR2021. https://t.co/tZyXQhZgLG https://t.co/x6AfItFWEU

Links:

Dr. John Cush RheumNow ( View Tweet)
Excellent talk on SLE, APS abs pregancy ⭐️pregnancy counseling is important ⭐️aspirin 81mg in all pregnant SLE pts ⭐️do not discontinue HCQ ⭐️stable LN - can switch MMF to AZA Abs#6888 #EULAR2021 @RheumNow

Robert B Chao, MD doctorRBC ( View Tweet)

Close call between LLDAS and DORIS Remission as a treat-to-target in #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/r3OnSrmQkH

Links:

Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)

Results are out. The majority would use #anifrolumab to treat refractory skin and joints disease #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/wguBCkhZ7B

Links:

Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)

6. Rheum disease activity was stable with COVID vaccination. (RA, PsA, axSpA, SLE - total n = 597) 7/ LB0003 #EULAR2021 @RheumNow https://t.co/xxkrunjPa0
David Liew drdavidliew ( View Tweet)
EULAR 2021 - Day 2 Podcasts Check out this compilation of our EULAR 2021 Day 2 broadcasts below. You can also follow the EULAR 2021 RheumNow podcasts on iTunes and Soundcloud. https://t.co/GskToSkfLk https://t.co/nF2FkHgBtu

Links:

Dr. John Cush RheumNow ( View Tweet)
We need to revisit #SLEDAI #lupus arthritis. Drs Mahmoud & Vital reported only 48% without swelling had MSK-US synovitis; 90% with swelling. They proposed new TERM: Inflammatory joint pain with =>2 SJC. Need to get this right as it impacts SRI-4 #EULAR2021 #POS0746 @RheumNow https://t.co/JPqOMLQ2ES
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×